DAX23.239 +0,6%Est505.529 +0,3%MSCI World4.343 -0,1%Top 10 Crypto12,37 +5,6%Nas22.846 +2,6%Bitcoin76.677 +1,7%Euro1,1525 +0,1%Öl63,29 +1,3%Gold4.117 +1,3%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
Rheinmetall 703000 Bayer BAY001 NVIDIA 918422 Novo Nordisk A3EU6F RENK RENK73 DroneShield A2DMAA Siemens Energy ENER6Y Lufthansa 823212 Alphabet A (ex Google) A14Y6F Deutsche Telekom 555750 HENSOLDT HAG000 TKMS thyssenkrupp Marine Systems TKMS00 Amazon 906866 BASF BASF11 Allianz 840400
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
DAX letztlich höher -- Novo Nordisk scheitert bei Alzheimer-Studie -- Deutsche Telekom, Alphabet, TKMS, D-Wave, DroneShield, Siemens Energy, Rheinmetall & Co., DHL, Bayer, Lufthansa, NEL im Fokus
Top News
Wie viel eine Ethereum Classic-Investition von vor 1 Jahr gekostet hätte Wie viel eine Ethereum Classic-Investition von vor 1 Jahr gekostet hätte
So lohnend wäre ein Einstieg in Bitcoin Cash von vor 1 Jahr gewesen So lohnend wäre ein Einstieg in Bitcoin Cash von vor 1 Jahr gewesen
Suche...
Login
ODER

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Rogers Aktie

Kaufen
Verkaufen
Rogers Aktien-Sparplan
69,00 EUR ±0,00 EUR ±0,00 %
FSE
79,74 USD -0,33 USD -0,41 %
BTT
Rogers jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 11/2024)
Smartphone

Marktkap.1,25 Mrd. EUR

KGV72,41Div. Rendite0,00%
WKN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

WKN863178

ISIN wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

ISINUS7751331015

Symbol wurde kopiert
NEU
Handle jetzt direkt über finanzen.net mit Deinem Broker
Direkt handeln

SymbolROG

Rogers Aktien News

DatumMeistgelesen
PR NewswireRoche's Elecsys® pTau181 becomes the only FDA-cleared blood test for use in primary care to rule out Alzheimer's-related amyloid pathology
PR NewswireCIBC to transfer 11 European Canadian Depositary Receipt listings to TSX
PR NewswireRoche achieves first CLIA 'Moderate Complexity' categorization for Ionify® 25-Hydroxy Vitamin D total test
Wer­bungRogers-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
PR NewswireRoche receives CE Mark for Accu-Chek SmartGuide Continuous Glucose Monitoring and mySugr App integration, offering an enhanced diabetes management experience
PR NewswireRoche receives CE Mark for Accu-Chek SmartGuide Continuous Glucose Monitoring and mySugr App integration, offering an enhanced diabetes management experience
PR NewswireRoche receives CE IVDR approval for HER2 (4B5) companion diagnostic test to identify HER2-ultralow breast cancer and biliary tract cancer patients
PR NewswireRoche receives CE IVDR approval for HER2 (4B5) companion diagnostic test to identify HER2-ultralow breast cancer and biliary tract cancer patients
PR NewswireRoche Diagnostics showcases science-driven leadership and innovation at ADLM 2025
PR NewswireRoche announces $550 million investment to expand its Indianapolis diagnostics manufacturing hub
PR NewswireCIBC introduces additional European Canadian Depositary Receipts ("CDRs")
PR NewswireCIBC introduces additional European Canadian Depositary Receipts ("CDRs")
PR NewswireRoche receives FDA clearance for new, highly-sensitive test to aid clinicians in diagnosing B-cell lymphoma
PR NewswireRoche's momentum in digital pathology continues with FDA clearance on its high-volume slide scanner
PR NewswireRoche receives FDA approval for first companion diagnostic to identify patients with biliary tract cancer eligible for HER2-targeted treatment with ZIIHERA
PR NewswireFlare Therapeutics Announces Strategic Discovery Collaboration with Roche to Address Previously Undrugged Transcription Factor Targets in Oncology
PR NewswireRoche receives FDA approval for the first companion diagnostic to identify patients with gastric and gastroesophageal junction cancer eligible for targeted treatment with VYLOY
PR NewswireSurvey commissioned by Roche shows that HPV infection, which causes 99% of all cervical cancer cases, remains largely misunderstood by the general public
PR NewswireSurvey commissioned by Roche shows that HPV infection, which causes 99% of all cervical cancer cases, remains largely misunderstood by the general public
PR NewswireRoche advances AI-driven cancer diagnostics by expanding its digital pathology open environment
PR NewswireRoche advances AI-driven cancer diagnostics by expanding its digital pathology open environment
PR NewswireRoche showcases solutions for laboratories of the future at the Association for Diagnostics & Laboratory Medicine 2024 Clinical Lab Expo
PR NewswireRoche receives FDA clearance on its digital pathology solution for diagnostic use
PR NewswireRoche and Hitachi High-Tech extend their 46-year partnership, paving the way for further breakthroughs in diagnostic testing
PR NewswireRoche and Hitachi High-Tech extend their 46-year partnership, paving the way for further breakthroughs in diagnostic testing
PR NewswireRoche obtains CE Mark for first companion diagnostic to identify patients with HER2-low metastatic breast cancer eligible for ENHERTU
PR NewswireRoche obtains CE Mark for first companion diagnostic to identify patients with HER2-low metastatic breast cancer eligible for ENHERTU
PR NewswireRoche showcases new navify® digital solutions that generate operational insights for faster decision-making in diagnostics at HIMSS¹ 2024
PR NewswireRoche showcases new navify® digital solutions that generate operational insights for faster decision-making in diagnostics at HIMSS¹ 2024
PR NewswireRoche showcases new navify® digital solutions that generate operational insights for faster decision-making in diagnostics at HIMSS¹ 2024
PR NewswireRoche showcases new navify® digital solutions that generate operational insights for faster decision-making in diagnostics at HIMSS¹ 2024
PR NewswireRoche enters into collaboration agreement with PathAI to expand digital pathology capabilities for companion diagnostics
PR NewswireRoche erhält IDC-Auszeichnung „Best in Future of Intelligence" für die Umsetzung der Data-Mesh-Strategie im großen Maßstab mit Immuta
PR NewswireRoche is awarded IDC Best in Future of Intelligence award for implementing data mesh strategy at scale with Immuta
PR NewswireRemix Therapeutics Enters Collaboration with Roche for the Discovery and Development of Small Molecule Therapeutics Modulating RNA Processing
PR NewswireRoche launches next-generation qPCR system to advance clinical needs in molecular diagnostics and address public health challenges
PR NewswireRoche collaborates with Ibex and Amazon Web Services to accelerate adoption of AI-enabled digital pathology solutions to help improve cancer diagnoses
PR NewswireRoche collaborates with Ibex and Amazon Web Services to accelerate adoption of AI-enabled digital pathology solutions to help improve cancer diagnoses
PR NewswireEconomist Impact report, Advancing the frontier of health and technology integration: The 2023 Digital Health Barometer highlights opportunities in digitalisation of healthcare
PR NewswireEconomist Impact report, Advancing the frontier of health and technology integration: The 2023 Digital Health Barometer highlights opportunities in digitalisation of healthcare
PR NewswireEconomist Impact report, Advancing the frontier of health and technology integration: The 2023 Digital Health Barometer highlights opportunities in digitalisation of healthcare

Rogers News

Rogers News: auf dieser Seite finden Sie alle Rogers News und Nachrichten zur Rogers Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Rogers News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Rogers News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.